This protocol is judged by an institutional critique board, an unbiased group that evaluations any medical trials involving human beings. If a research involves a Plan I drug, after the board approves the protocol as ethical, the scientists should submit an application for an investigational new drug (IND) selection from your FDA.Weiser urged socia